Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Hepatitis A transmission by factor IX concentrates.

Lawlor E, Graham S, Davidson E, Yap PL, Cunningham C, Daly H, Temperley IJ.

Vox Sang. 1996;71(2):126-8.

PMID:
8873425
2.

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.

Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson SU, Purcell RH.

Ann Intern Med. 1994 Jan 1;120(1):1-7.

PMID:
7504424
3.
4.

Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.

Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M, Musso R, Santoro R, Schiavoni M.

Transfusion. 1997 May;37(5):517-22.

PMID:
9149778
5.

A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool.

Chudy M, Budek I, Keller-Stanislawski B, McCaustland KA, Neidhold S, Robertson BH, Nübling CM, Seitz R, Löwer J.

J Med Virol. 1999 Feb;57(2):91-9.

PMID:
9892390
6.

Failure to detect hepatitis A virus RNA in factor VIII concentrates using the polymerase chain reaction. Results of a preliminary study.

McOmish F, Yap PL, Hart H, Peerlinck K, Burns SM, Simmonds P.

Vox Sang. 1994;67 Suppl 1:47-50.

PMID:
8091737
7.

Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentrates.

Chudy M, Stahl-Hennig C, Berger A, Nübling CM, Hunsmann G, Rabenau HF, Löwer J.

J Infect Dis. 2002 Apr 15;185(8):1170-3.

8.

Prothrombin complex concentrates for clinical use.

Chandra S, Brummelhuis HG.

Vox Sang. 1981 Nov-Dec;41(5-6):257-73. Review.

PMID:
6798760
9.

An outbreak of hepatitis A among South African patients with hemophilia: evidence implicating contaminated factor VIII concentrate as the source.

Kedda MA, Kew MC, Cohn RJ, Field SP, Schwyzer R, Song E, Fernandes-Costa F.

Hepatology. 1995 Nov;22(5):1363-7.

PMID:
7590648
10.

Assessment for evidence of non A-non B hepatitis in patients given n-heptane-suspended heat-treated clotting factor concentrates.

Carnelli V, Gomperts ED, Friedman A, Aledort L, Hilgartner M, Dietrich S, Fedor EJ.

Thromb Res. 1987 Jun 15;46(6):827-34.

PMID:
3114910
11.

Inactivation of hepatitis A virus in plasma products by vapor heating.

Barrett PN, Meyer H, Wachtel I, Eibl J, Dorner F.

Transfusion. 1997 Feb;37(2):215-20.

PMID:
9051099
12.
13.

Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.

Robertson BH, Alter MJ, Bell BP, Evatt B, McCaustland KA, Shapiro CN, Sinha SD, Souci JM.

Biologicals. 1998 Jun;26(2):95-9. Review.

PMID:
9811512
14.

Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.

Modrow S, Wenzel JJ, Schimanski S, Schwarzbeck J, Rothe U, Oldenburg J, Jilg W, Eis-Hübinger AM.

Vox Sang. 2011 May;100(4):351-8. doi: 10.1111/j.1423-0410.2010.01445.x.

PMID:
21133933
15.

Hepatitis B virus associated DNA polymerase inactivation in factor IX concentrates.

Mitra G, Ng PK.

Thromb Res. 1986 Feb 1;41(3):291-300.

PMID:
3705011
16.

Absence of hepatitis A virus transmission by high-purity solvent detergent treated coagulation factor concentrates in Scottish haemophiliacs.

Watson HG, Ludlam CA, McOmish F, Dennis R, Hart H, Simmonds P.

Br J Haematol. 1995 Jan;89(1):214-6.

PMID:
7833268
17.

A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate.

Goudemand J, Peynet J, Chambost H, Négrier C, Briquel ME, Claeyssens S, Derlon-Borel A, Guérois C, Caron C, Scherrmann JM, Debray M, Bridey F.

Thromb Haemost. 1998 Dec;80(6):919-24.

PMID:
9869161
18.

Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.

Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM.

J Lab Clin Med. 1993 Mar;121(3):394-405.

PMID:
8445288
19.

Prothrombin complex concentrates: clinical use.

Menache D.

Ann N Y Acad Sci. 1981;370:747-56. Review. No abstract available.

PMID:
6791551
20.

An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients.

Berntorp E, Petrini P, Dockter G, Tengborn L, Wendisch I, Eberl W, Aumann V, Frade G, Seliger I, Engl W, Ehrlich H.

Haemophilia. 2001 Jul;7(4):360-3.

PMID:
11442639
Items per page

Supplemental Content

Support Center